Literature DB >> 32479767

Isolation, in vitro evaluation and molecular docking of acetylcholinesterase inhibitors from South African Amaryllidaceae.

Mary Nokuthula Sibanyoni1, Sushil Kumar Chaudhary1, Weiyang Chen1, Hamid-Reza Adhami2, Sandra Combrinck3, Vinesh Maharaj4, Daniela Schuster5, Alvaro Viljoen6.   

Abstract

Inhibition of acetylcholinesterase (AChE) is considered a promising strategy for the treatment of Alzheimer's disease (AD) and dementia. Members of the Amaryllidaceae family are well known for their pharmacologically active alkaloids, including galanthamine, which is used to treat AD. The aim of this study was to evaluate the potential of South African Amaryllidaceae species to inhibit AChE, to isolate the active compounds, and probe their ability to bind the enzyme using molecular docking. The AChE inhibitory activity of extracts of 41 samples, representing 14 genera and 28 species, as well as isolated compounds, were evaluated in vitro using a qualitative thin layer chromatography (TLC) bio-autography assay and Ellman's method in a quantitative 96-well microplate assay. Targeted isolation of compounds was achieved with the aid of preparative-high perfomance liquid chromatography-mass spectrometry. The structures of the isolates were elucidated using nuclear magnetic resonance spectrocopy, and were docked into the active site of AChE to rationalise their biological activities. The most active species were found to be Amaryllis belladonna L (IC50 14.3 ± 2.6 μg/mL), Nerine huttoniae Schönland (IC50 45.3 ± 0.4 μg/mL) and Nerine undulata (L.) Herb. (IC50 52.8 ± 0.5 μg/mL), while TLC bio-autography indicated the presence of several active compounds in the methanol extracts. Four compounds, isolated from A. belladonna, were identified as belladine, undulatine, buphanidrine and acetylcaranine. Acetylcaranine and undulatine were previously isolated from A. belladonna, while belladine and buphanidrine were reported from other South African Amaryllidaceae species. Using Ellman's method, acetylcaranine was found to be the most active of the isolates towards AChE, with an IC50 of 11.7 ± 0.7 μM, comparable to that of galanthamine (IC50 = 6.19 ± 2.60 μM). Molecular docking successfully predicted the binding modes of ligands within receptor binding sites. Acetylcaranine was predicted by the docking workflow to have the highest activity, which corresponds to the in vitro results. Both qualitative and quantitative assays indicate that several South African Amaryllidaceae species are notable AChE inhibitors.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholinesterase inhibition; Alzheimer's disease; Amaryllidaceae; Galanthamine; Molecular docking

Mesh:

Substances:

Year:  2020        PMID: 32479767     DOI: 10.1016/j.fitote.2020.104650

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  5 in total

1.  Alpha-glucosidase inhibitors from Nervilia concolor, Tecoma stans, and Bouea macrophylla.

Authors:  Kim-Ngoc Ha; Tran-Van-Anh Nguyen; Dinh-Tri Mai; Nguyen-Minh-An Tran; Ngoc-Hong Nguyen; Giau Van Vo; Thuc-Huy Duong; Huy Truong Nguyen
Journal:  Saudi J Biol Sci       Date:  2021-09-30       Impact factor: 4.219

2.  Supercritical CO2 assisted extraction of essential oil and naringin from Citrus grandis peel: in vitro antimicrobial activity and docking study.

Authors:  Thanh-Chi Mai; Ngoc-Thinh Tran; Dinh-Tri Mai; Tran Thi Ngoc Mai; Nguyen Hong Thuc Duyen; Tran Nguyen Minh An; Mahboob Alam; Chi-Hien Dang; Thanh-Danh Nguyen
Journal:  RSC Adv       Date:  2022-09-13       Impact factor: 4.036

3.  In silico and in vitro studies on the anti-cancer activity of artemetin, vitexicarpin and penduletin compounds from Vitex negundo.

Authors:  Giau Van Vo; Thi-Hoai-Thu Nguyen; Thi-Phuong Nguyen; Thi-Hong-Tuoi Do; Nguyen-Minh-An Tran; Huy Truong Nguyen; Thuy Trang Nguyen
Journal:  Saudi Pharm J       Date:  2022-06-22       Impact factor: 4.562

4.  Neuroprotective Activities of Crossyne flava Bulbs and Amaryllidaceae Alkaloids: Implications for Parkinson's Disease.

Authors:  Sylvester I Omoruyi; Abobaker S Ibrakaw; Okobi E Ekpo; James S Boatwright; Christopher N Cupido; Ahmed A Hussein
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

Review 5.  Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer's Disease.

Authors:  Lucie Cahlíková; Rudolf Vrabec; Filip Pidaný; Rozálie Peřinová; Negar Maafi; Abdullah Al Mamun; Aneta Ritomská; Viriyanata Wijaya; Gerald Blunden
Journal:  Molecules       Date:  2021-08-29       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.